Piperidines are widely found in biologically active compounds, and accessing these N-heterocycles from pyridines is a commonly used strategy. However, this approach is challenging when pyridines are embedded in complex structures, such as those found in pharmaceutical compounds. Here, we present a sequential approach to piperidines that commences with a hydride addition to NTf-activated pyridinium salts. In this method, we combined tris(pentafluorophenyl)borane as a catalyst with a silane reducing agent to achieve 4-selective mon-reduction, and then combined it with metal-catalyzed reductions to obtain tetrahydropiperidine and piperidine derivatives. The process operates on a broad range of pyridines with various functional groups and substitution patterns, as well as on pyridine-containing drugs.
Building similarity graph...
Analyzing shared references across papers
Loading...
Celena M. Josephitis
Andrew McNally
Synthesis
Colorado State University
Building similarity graph...
Analyzing shared references across papers
Loading...
Josephitis et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6971bdad642b1836717e24a0 — DOI: https://doi.org/10.1055/a-2784-2600
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: